Skip to content
Clinic and treatment

What Happens Between Screening and Embryo Transfer

What Happens Between Screening and Embryo Transfer

The quiet period before transfer is not empty time. It is when clinical, legal and practical plans are checked against one another.

After preliminary screening, the licensed clinic confirms medical suitability and the individual treatment plan, while agreements, consent, embryo records and practical arrangements are completed. Medication and monitoring begin only on the clinic’s instruction, and the transfer date remains provisional until the clinical team confirms readiness.

Screening closes questions; it also opens new ones

A screening pathway may include review of pregnancy history, current health, examinations, laboratory testing and psychosocial assessment. Passing one part does not automatically complete the others. The clinic may request an older delivery record, repeat a test or ask another specialist to clarify something that is likely manageable but still needs an informed decision.

This is a normal reason for the schedule to remain flexible. The useful question is not simply whether screening is ‘passed’, but who has issued the decision, what conditions apply and whether the prospective surrogate mother has received an explanation she understands. A coordinator can track documents; only the treating team can make the medical judgment.

Embryo information and the treatment plan must meet

The clinic needs accurate information about the embryos and the intended treatment. Storage location, laboratory records, infectious-disease documentation, transport arrangements and any genetic testing can affect what has to be prepared. If embryos are moving between clinics or countries, responsibility for the chain of custody should be clear before medication creates time pressure.

At the same time, the surrogate mother receives an individual protocol. She should know which medicines are prescribed, how to take them, what monitoring is required, who to contact about side effects and what would cause the cycle to pause. A calendar is helpful, but it is not a substitute for direct clinical instructions.

Consent and agreements need breathing room

The period before medication is the time to finish independent agreement review and ask unresolved questions. The written arrangement should make communication, expenses, decision-making boundaries and difficult contingencies understandable. Clinical consent is a separate, continuing process between the patient and the healthcare team.

Rushing signatures because a transfer slot has appeared reverses the proper order. Everyone should have time to read, seek independent advice and request translation where needed. A well-prepared programme protects the freedom to pause even when considerable effort has already gone into planning.

Use one shared readiness check before transfer

A short multidisciplinary check can prevent avoidable confusion. Confirm that the clinic has cleared the patient and embryo plan, the parties understand the agreement, medication has been dispensed correctly, monitoring appointments are booked, transport and childcare are workable, and the right people know how results will be communicated.

The point is not to create bureaucracy. It is to make sure a clinical instruction does not depend on an unconfirmed legal or practical assumption. Once the clinic confirms readiness, everyone can enter transfer day knowing what happens next, who reports the result and how support continues during the waiting period.

Helpful answers

Questions readers ask about before embryo transfer

Clear answers for real decisions: what to prepare, who is responsible and what can change the plan.

There is no responsible universal interval. Timing depends on completion of clinic review, the embryo plan, agreements and consent, the surrogate mother’s cycle and protocol, and any additional records or tests. The team can provide a working sequence, but the licensed clinic confirms when treatment can actually proceed.

They should have an appropriate route for questions about their embryos and the treatment plan, while the surrogate mother’s confidential healthcare and consent remain protected. The clinic and coordinator should explain which information can be shared, who receives updates and how the patient participates in each decision.

The clinic may request another test, a specialist opinion, treatment of a temporary issue or a pause. The result should be explained to the prospective surrogate mother directly. A follow-up request is not automatically rejection, but neither should anyone minimise it to preserve a proposed transfer date.

Book only after the treating team and coordinator explain how firm the timing is, and choose changeable arrangements where possible. Clinical response, embryo logistics and document readiness can alter the schedule. Intended parents should also confirm whether their physical presence is required or simply preferred for the planned clinic step.

Private & by appointment

Book a private Zoom or WhatsApp call.

Choose the call format and tell us a convenient time. We will confirm the appointment and prepare for your first questions.